Leadless Cardiac Pacing Using Acoustic Power Transfer

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing cardiac pacing technologies rely on lead wires, which are prone to complications such as infection, lead failure, and limited accessibility, restricting the ability to stimulate at multiple sites.

Innovation Solution

A leadless tissue stimulation system utilizing a receiver-stimulator implanted at the heart and a controller-transmitter remotely positioned, communicating via acoustic and radiofrequency signals to deliver electrical stimulation, with energy harvesting and sensor capabilities.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If lead wires are used to deliver electrical stimulation to cardiac tissue, then reliable electrical connection can be achieved, but complications such as infection, lead failure, and electrode dislodgement occur

Engineering Contradiction:
Improveelectrical connection reliabilityVSAvoidinfection and lead failure
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent removes the lead wire component from the pacing system by implementing a leadless pacemaker design. The receiver-stimulator is implanted directly in the heart chamber, eliminating the need for subcutaneous pockets and transvenous leads, thereby removing the source of lead-related infections and mechanical failures while maintaining reliable electrical connection through direct cardiac contact

Inventive Principle:
Principle #2Taking out (Extraction)

2Adaptability or versatility

If lead wires are used for tissue stimulation, then electrical energy can be delivered to cardiac tissue, but the number of accessible locations and ability to stimulate at multiple sites is limited

Engineering Contradiction:
Improvenumber of stimulation sitesVSAvoidlead wire system complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent divides the pacing system into separate functional modules: a controller-transmitter positioned externally and receiver-stimulators implanted directly in the heart. This segmentation allows multiple receiver-stimulators to be placed at different cardiac locations independently, enabling multi-site stimulation without the complexity of routing multiple leads through veins and managing multiple connection points

Inventive Principle:
Principle #1Segmentation

3Object-affected harmful factors

If a leadless receiver-stimulator is implanted in the heart, then lead-related complications are eliminated, but the system requires wireless energy transmission and acoustic signaling

Engineering Contradiction:
Improvelead-related complicationsVSAvoidwireless communication system
Core Design Contradiction:
Object-affected harmful factorsVSDevice complexity

Solution Approach 1:

The patent replaces the mechanical lead wire connection system with wireless acoustic and electromagnetic communication. The controller-transmitter uses acoustic waves to communicate with the implanted receiver-stimulator and electromagnetic fields for energy transfer, eliminating mechanical connections while managing system complexity through integrated wireless protocols

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables reliable cardiac pacing without lead-related complications, allowing for multiple stimulation sites and improved patient comfort and efficacy.

Implementation Method 1

a transducer circuit configured to receive at least a portion of the acoustic signal and convert the acoustic signal to electrical energy

Methodology Applied
Scientific EffectAcoustic energy conversion: Piezoelectric Effect

Implementation Method 2

a fourth circuit configured to transmit the radiofrequency signal to the second circuit of the controller-transmitter

Methodology Applied
Scientific EffectRadiofrequency transmission: Electromagnetic Induction

Data Source

PatentUS20250360319A1Tissue stimulation systems and methods, such as for pacing cardiac tissue
Publication Date: 2025.11.27 EBR SYSTEMS INC
  • US20250360319A1 patent drawing
  • US20250360319A1 patent drawing
  • US20250360319A1 patent drawing

AI summary

The present technology is generally directed to implantable medical device systems for stimulating tissue, such as heart tissue. In some embodiments, an implantable medical device system includes a controller-transmitter and a receiver-stimulator in operable communication with one another. The receiver-stimulator can be implanted at the heart of a patient. The controller-transmitter can be configured to transmit an acoustic signal to the receiver-stimulator, which receives the acoustic signal and converts the acoustic signal to electrical energy for delivery to the heart via one or more stimulation electrodes. The receiver-stimulator can further be configured to transmit a radiofrequency signal to the controller-transmitter including information about sensed physiological parameters of the patient, status information, and the like.